FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 354:1339-1341 March 30, 2006 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Interview Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

A recent survey by the Kaiser Family Foundation quantifies what many of us have seen firsthand: the new Medicare drug benefit is having a troubled infancy (see bar graphs). The data reflect the experience of elderly people who were well enough to participate in a survey; other reports make clear that matters are far worse for those with medical or cognitive disabilities.

View larger version (15K):   Impressions of the Medicare Drug Benefit (Panel A) and Level of Understanding of the Benefit (Panel B) among Respondents Older Than 65 Years. Data are from the Kaiser Family Foundation Health Poll Report Survey, conducted February 2–7, . . . [Full Text of this Article]

 

Source Information

Dr. Avorn is a professor of medicine at Harvard Medical School and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital — both in Boston.

An interview with Dr. Avorn can be heard at www.nejm.org.

This article has been cited by other articles:

• Iezzoni, L.I., Ngo, L.H., Kinkel, R.P. (2008). Working-age persons with multiple sclerosis and access to disease-modifying medications. Mult Scler 14: 112-122 [Abstract]  
• De Natale, M. L. (2007). Understanding the Medicare Part D Prescription Program: Partnerships for Beneficiaries and Health Care Professionals. Policy Politics Nursing Practice 8: 170-181 [Abstract]  
• Stubbings, J., Durley, S. F., Lin, S.-J., Kliethermes, M., Aruru, M. D., Evangelista, C., Byun, M. (2007). Implementing the Medicare drug benefit in a diverse inner-city community. Am J Health Syst Pharm 64: 193-199 [Abstract] [Full Text]  
• Federman, A. D., Alexander, G. C., Shrank, W. H. (2006). A Practical Physicians' Guide to the Medicare Drug Benefit Plan. Mayo Clin. Proc. 81: 1217-1221 [Full Text]